Diabetes in the Pediatric Population-can Stem Cell Therapy Overcome the Associated Burden Disease

A cutting-edge review in the American Journal of Biomedical Science & Research explores a question that could reshape the future for millions of children: Can stem cell therapy reverse the course of Type 1 Diabetes in the pediatric population?

Authored by an international team including European Wellness founder Prof. Dato’ Sri Dr. Mike Chan and Prof. Dato’ Sri Dr. Michelle Wong, this pivotal paper examines how mesenchymal, hematopoietic, and pluripotent stem cells might not only shield β-cells from autoimmune attacks but also regenerate insulin-producing function. 🧬

Key Highlights:

✅ Immune Resetting with HSCs shows potential in stopping early-stage autoimmune destruction.

✅ MSC Therapies demonstrate glycemic control benefits with immunomodulation.

✅ iPSCs & ESCs pave the way for personalized β-cell regeneration.

✅ Pediatric Trials reveal encouraging early safety and efficacy signals.

The findings suggest stem cells could one day offer more than just ‘disease management’ for children around the world who suffer from this disease…

MORE PUBLICATIONS:
https://european-wellness.eu/publications/